Carroll Financial Associates’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$1.27M Buy
22,666
+340
+2% +$19K 0.07% 161
2021
Q3
$1.07M Buy
22,326
+76
+0.3% +$3.65K 0.06% 179
2021
Q2
$932K Sell
22,250
-110
-0.5% -$4.61K 0.05% 184
2021
Q1
$753K Hold
22,360
0.05% 200
2020
Q4
$780K Hold
22,360
0.05% 184
2020
Q3
$776K Buy
22,360
+76
+0.3% +$2.64K 0.06% 168
2020
Q2
$729K Buy
22,284
+612
+3% +$20K 0.06% 172
2020
Q1
$652K Hold
21,672
0.06% 169
2019
Q4
$627K Sell
21,672
-1,206
-5% -$34.9K 0.05% 196
2019
Q3
$591K Sell
22,878
-732
-3% -$18.9K 0.05% 191
2019
Q2
$602K Buy
23,610
+738
+3% +$18.8K 0.05% 188
2019
Q1
$598K Buy
22,872
+19,392
+557% +$507K 0.06% 172
2018
Q4
$82K Hold
3,480
0.01% 413
2018
Q3
$82K Buy
3,480
+4
+0.1% +$94 0.01% 434
2018
Q2
$80K Buy
3,476
+442
+15% +$10.2K 0.01% 428
2018
Q1
$74K Buy
3,034
+1,000
+49% +$24.4K 0.01% 431
2017
Q4
$54K Buy
2,034
+286
+16% +$7.59K 0.01% 470
2017
Q3
$42K Buy
1,748
+4
+0.2% +$96 ﹤0.01% 526
2017
Q2
$37K Buy
1,744
+4
+0.2% +$85 ﹤0.01% 552
2017
Q1
$29K Hold
1,740
﹤0.01% 586
2016
Q4
$31K Hold
1,740
﹤0.01% 547
2016
Q3
$36K Sell
1,740
-48
-3% -$993 0.01% 527
2016
Q2
$48K Buy
1,788
+1,100
+160% +$29.5K 0.01% 452
2016
Q1
$18K Sell
688
-442
-39% -$11.6K ﹤0.01% 634
2015
Q4
$32K Sell
1,130
-520
-32% -$14.7K 0.01% 477
2015
Q3
$44K Sell
1,650
-260
-14% -$6.93K 0.01% 420
2015
Q2
$52K Buy
1,910
+1,356
+245% +$36.9K 0.01% 365
2015
Q1
$15K Buy
554
+54
+11% +$1.46K 0.01% 469
2014
Q4
$11K Sell
500
-190
-28% -$4.18K 0.01% 473
2014
Q3
$15K Buy
690
+440
+176% +$9.57K ﹤0.01% 501
2014
Q2
$6K Hold
250
﹤0.01% 682
2014
Q1
$6K Hold
250
﹤0.01% 625
2013
Q4
$4K Hold
250
﹤0.01% 645
2013
Q3
$4K Buy
+250
New +$4K ﹤0.01% 635